EP1.18-19 Patients with Unresectable Stage III Non-Small Cell Lung Cancer Eligible to Receive Durvalumab in Clinical Practice

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 14; no. 10; p. S1103
Main Authors Furuhashi, K., Hataji, O., Nakamura, Y., Suzuki, Y., Sakaguchi, T., Ito, K., Fujiwara, K., Nishii, Y., Taguchi, O.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2019
Online AccessGet full text

Cover

Author Hataji, O.
Fujiwara, K.
Taguchi, O.
Ito, K.
Nishii, Y.
Sakaguchi, T.
Suzuki, Y.
Furuhashi, K.
Nakamura, Y.
Author_xml – sequence: 1
  givenname: K.
  surname: Furuhashi
  fullname: Furuhashi, K.
– sequence: 2
  givenname: O.
  surname: Hataji
  fullname: Hataji, O.
– sequence: 3
  givenname: Y.
  surname: Nakamura
  fullname: Nakamura, Y.
– sequence: 4
  givenname: Y.
  surname: Suzuki
  fullname: Suzuki, Y.
– sequence: 5
  givenname: T.
  surname: Sakaguchi
  fullname: Sakaguchi, T.
– sequence: 6
  givenname: K.
  surname: Ito
  fullname: Ito, K.
– sequence: 7
  givenname: K.
  surname: Fujiwara
  fullname: Fujiwara, K.
– sequence: 8
  givenname: Y.
  surname: Nishii
  fullname: Nishii, Y.
– sequence: 9
  givenname: O.
  surname: Taguchi
  fullname: Taguchi, O.
BookMark eNp90LFOwzAQBmALgURbeAIWv0CCnTiOMzCgUCBSBRWls-XY59ZV6iAnLWLg3UnUzix3N9x_On1TdOlbDwjdURJTQvn9Lt712zZOCC1iIuKEcXaBJjTLeERTQS7PMxGcXaNp1-0IYRlhYoJ-50saUxHRAi9V78D3Hf52_RavfYAOdK_qBvCqVxvAVVXht9ZHq71qGlzCUBYHv8Gl8hoCnjdu48btvsUfoMEdAT8dwlE1h72qsfO4bJx3WjV4GZTunYYbdGVV08Htuc_Q-nn-Wb5Gi_eXqnxcRJqylEW55SbhXCQ6F3VGOC9yZolNQTMNBXBbGGU4syoRGTVZndHCGqNrnQDLa52mM5Se7urQdl0AK7-C26vwIymRo6DcyVFQjoKSCDkKDqmHUwqG144Oguz0IKTBuDDISNO6f_N_MLh8LQ
ContentType Journal Article
Copyright 2019
Copyright_xml – notice: 2019
DBID AAYXX
CITATION
DOI 10.1016/j.jtho.2019.08.2464
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1556-1380
EndPage S1103
ExternalDocumentID 10_1016_j_jtho_2019_08_2464
S1556086419331478
GroupedDBID ---
.55
.XZ
.Z2
0R~
457
53G
5GY
5VS
6I.
9UZ
AACTN
AAEDW
AAFTH
AAIAV
AAKAS
AALRI
AAWTL
AAXUO
ABBUW
ABJNI
ABMAC
ABPMR
ABVKL
ACDDN
ACGFS
ACWDW
ACWRI
ADBBV
ADBIZ
ADEZE
ADZCM
AE3
AENEX
AEXQZ
AFTJW
AFTRI
AGHFR
AHPSJ
AITUG
AIZYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AWKKM
BOYCO
C45
CS3
DU5
E.X
EBS
EJD
EX3
F5P
FDB
FL-
HZ~
IN~
KD2
NCXOZ
NTWIH
O9-
OFXIZ
OGEVE
OK1
OVD
P2P
ROL
S4S
SSZ
TEORI
V2I
W3M
WOQ
WOW
X7M
0SF
AAYXX
ADVLN
AFETI
AFJKZ
AKRWK
CITATION
ID FETCH-LOGICAL-c1434-7f6d26682c78b5066974f0f3ec4ce9e6f9dad64fa2851d5b519fddcbc2e47bc33
IEDL.DBID ABVKL
ISSN 1556-0864
IngestDate Thu Sep 26 17:06:03 EDT 2024
Fri Feb 23 02:49:30 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1434-7f6d26682c78b5066974f0f3ec4ce9e6f9dad64fa2851d5b519fddcbc2e47bc33
OpenAccessLink http://www.jto.org/article/S1556086419331478/pdf
ParticipantIDs crossref_primary_10_1016_j_jtho_2019_08_2464
elsevier_sciencedirect_doi_10_1016_j_jtho_2019_08_2464
PublicationCentury 2000
PublicationDate October 2019
2019-10-00
PublicationDateYYYYMMDD 2019-10-01
PublicationDate_xml – month: 10
  year: 2019
  text: October 2019
PublicationDecade 2010
PublicationTitle Journal of thoracic oncology
PublicationYear 2019
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0045048
Score 2.309826
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage S1103
Title EP1.18-19 Patients with Unresectable Stage III Non-Small Cell Lung Cancer Eligible to Receive Durvalumab in Clinical Practice
URI https://dx.doi.org/10.1016/j.jtho.2019.08.2464
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3NS8MwFMDDVBAv4ifOL3LwaNzapkl61Dlx7oOhTr2VJk10Y-vGrEf_d1_aFBTEg5eGlgTCS_PeL8l7LwidGSOkUEoRoE-fUCAOIlgoCReGizSVPCo29PsDdjuidy_hSw21qlgY61bpdH-p0wtt7b40nDQbi_G48QCWkAGQU0CQwKNcrKA1H-gXZufa5dVTt1cpZOhAcYmWrU9sgyr5UOHmNcnfbAygF9lMnj5l9HcD9c3o3GyhTUeL-LLs0Daq6WwHrffdefgu-mwPvQsPFmgRHpYJUt-x3VnFoyKLj8ptYBQGoHzVuNPp4ME8Iw-zZDrFLQ2PHsx03LLjvsRt65psa-dzDCypQQvi64-lTQY-SyQeZ9ilEJ3ioYus2kOjm_Zj65a4CxWIAiyihBuWgkEWvuJChgAbsJgwTRNoRZWONDNRmqSMmsQHDktDCXRn0lRJ5WvKpQqCfbSazTN9gLCW1NOepExxQ8OES2YC5iXUAD5C2ayj80qK8aLMmxFXDmWT2Ao9tkKPmyK2Qq8jVkk6_jH8MWj2vxoe_rfhEdqwr6Vf3jFazZcf-gT4Ipen7v-xZff-ufsF4I7Ofw
link.rule.ids 315,783,787,27581,27936,27937,45675
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1BT9swFMefoEhjF8QYaIzBfNgR0yZxbOfIuqJ2tFUlKOJmxY7NikqKSjjy3fecONImIQ5cEimxJes5ee9n571_AH44J7U0xlCkz5gyJA4qeaqpkE7IotAiqzf0J1M-nLPft-ntBvTbWhifVhl8f-PTa28drnSDNbuPi0X3CiMhRyBniCBJxITchC2kAZF2YOv8583luHXIOID6J1q-PfUdWvGhOs3rvvrjawCjzCt5xoyz1wPUP0HnYhd2Ai2S82ZAn2DDlnvwYRK-h3-Gl8EsOotwgZaRWSOQ-kT8ziqZ1yo-pvKFUQSB8s6S0WhEpquSXj3kyyXpWzyM8U0nfT_vazLwqcm-dbUiyJIWvSD59bz2YuAPuSaLkgQJ0SWZhcqqfZhfDK77Qxp-qEANYhGjwvECA7KMjZA6RdjAxYTrucQaZmxmucuKvODM5TFyWJFqpDtXFEab2DKhTZIcQKdclfYLEKtZZCPNuBGOpbnQ3CU8yplDfMRz7xBOWyuqx0Y3Q7UJZffKG115o6ueVN7oh8BbS6v_pl-hZ3-r49f3dvwO28PryViNR9PLI_jobzU5et-gU62f7TGyRqVPwrP0FzfZz8o
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=EP1.18-19+Patients+with+Unresectable+Stage+III+Non-Small+Cell+Lung+Cancer+Eligible+to+Receive+Durvalumab+in+Clinical+Practice&rft.jtitle=Journal+of+thoracic+oncology&rft.au=Furuhashi%2C+K.&rft.au=Hataji%2C+O.&rft.au=Nakamura%2C+Y.&rft.au=Suzuki%2C+Y.&rft.date=2019-10-01&rft.pub=Elsevier+Inc&rft.issn=1556-0864&rft.eissn=1556-1380&rft.volume=14&rft.issue=10&rft.spage=S1103&rft.epage=S1103&rft_id=info:doi/10.1016%2Fj.jtho.2019.08.2464&rft.externalDocID=S1556086419331478
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1556-0864&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1556-0864&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1556-0864&client=summon